CVR 39859173Private limited company (ApS)Fremstilling af farmaceutiske præparater (212000)København NFounded 10 Sep 2018
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Cymab ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
2
CVR registry, Aug 2026
-1 (-33.3%) over 12 months
Gross profit
-5.5M
DKK, annual report 2025
Result
-7.6M
DKK, annual report 2025
Equity
-20.2M
DKK, annual report 2025
Ebumab Holding ApSCVR 39807556, 100% of capital and votes, since 10 Sep 2018
Johan Henrik Fabersince 1 Jun 2019
Equity was negative at 31 Dec 2025: -20.2M DKK. Dandex estimate, computed 8 Nov 2026.
CVR 39807556100% of capital and votessince 10 Sep 2018
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Ultimate controller
Holds 50% to under 66.7% of capital and 66.7% to under 90% of votes in Johan H. Faber ApS, since 5 Dec 2018
Holding company
CVR 40107606Private limited company (ApS)
Holds 50% to under 66.7% of capital and votes in Ebumab Holding ApS, since 1 Jun 2019
Holding company
CVR 39807556Private limited company (ApS)
Holds 100% of capital and votes in Cymab ApS, since 10 Sep 2018
This company
Cymab ApS
CVR 39859173
CVR records founders at incorporation. It does not record whether they are alive or still involved.
10 Sep 2018 to 8 Nov 2026.
10 Sep 2018 to 8 Nov 2026.
Aug 2026, monthly: 2 employees, 2 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 4 | 3 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
| FTE | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 4 | 3 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Oct 2021 to Aug 2026.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Not reported | 0 | Not reported | Not reported | Not reported |
| Gross profit | Not reported | Not reported | -1,206 | -1,952 | -5,463 |
| Operating profit | Not reported | -1,912 | -3,178 | -5,502 | -8,587 |
| Result for the year | -943 | -1,541 | -2,581 | -4,628 | -7,576 |
| Equity | -3,902 | -5,443 | -8,024 | -12,651 | -20,227 |
| Total assets | 383 | 5,166 | 5,556 | 12,611 | 5,779 |
| Employees (average) | 1 | 2 | 2 | 3 | 3 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA | -733note 1 | -1,909 | -3,175 | -5,500 | -8,587 |
| Employee growth (vækst i antal ansatte) | n.m.note 2 | 100% | 0% | 50% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -238 | 415 | 4,787 | 7,845 | 17,859 |
| Capex (investeringer i anlægsaktiver) | 0note 3 | 0note 3 | 0note 3 | 0note 3 | Not reportednote 4 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 3,930 | 5,319 | 9,436 | 12,339 | 21,938 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 25 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 16 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 29 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 30 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 21 Jun 2022
Each registered value from the day it took effect, newest first.
From CVR, read 8 Nov 2026. Text such as the signing rule and purpose is shown as registered.
15 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Vedtægter ændret: 17.04.2026
Bestyrelse:
Fratrådte:
Anne Reker Cordt, den 06.02.2026.
Direktion:
Fratrådte:
Anne Reker Cordt, den 06.02.2026.
Vedtægter ændret: 25.03.2025
Vedtægter ændret: 25.03.2025
Revision:
Fratrådte:
Johnny Kofoed-Jensen Statsautoriseret Revisionsanpartsselskab, den 25.02.2025.
Tiltrådte:
CVR-NR. 32895468 Beierholm Godkendt Revisionspartnerselskab, Roskildevej 12A, 3400 Hillerød, den 25.02.2025.
Bestyrelse:
Tiltrådte:
Anne Reker Cordt, den 24.06.2024.
Direktion:
Tiltrådte:
Anne Reker Cordt, den 24.06.2024.
Direktion:
Fratrådte:
Stine Louise Reedtz Kjellev, den 31.05.2024.
Vedtægter ændret: 16.10.2023
Vedtægter ændret: 18.09.2023
Vedtægter ændret: 17.04.2023
Nyt navn: Cymab ApS
Bestyrelse:
Fratrådte:
Thomas Dal Stenfeldt Batchelor, (formand), den 17.04.2023, Hans Heugh Wandall, den 17.04.2023.
Tiltrådte:
Thomas Dal Stenfeldt Batchelor, den 17.04.2023, Mads Nikolaj Behrndt-Eriksen, den 17.04.2023, Hans Heugh Wandall, (formand), den 17.04.2023.
Direktion:
Fratrådte:
Johan Henrik Faber, den 17.04.2023, Hans Heugh Wandall, (adm. dir), den 17.04.2023.
Tiltrådte:
Johan Henrik Faber, (adm. dir), den 17.04.2023, Stine Louise Reedtz Kjellev, den 17.04.2023.
Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af den samlede bestyrelse.
Bestyrelse:
Fratrådte:
Thomas Dal Stenfeldt Batchelor, den 21.05.2021, Hans Heugh Wandall, (formand), den 21.05.2021.
Tiltrådte:
Thomas Dal Stenfeldt Batchelor, (formand), den 21.05.2021, Hans Heugh Wandall, den 21.05.2021.
Direktion:
Tiltrådte:
Hans Heugh Wandall, (adm. dir), den 21.05.2021.
Revision:
Fratrådte:
KAPPELSKOV REVISION. GODKENDT REVISIONSAKTIESELSKAB, den 15.07.2020.
Tiltrådte:
CVR-NR. 40992138 Johnny Kofoed-Jensen Statsautoriseret Revisionsanpartsselskab, Manenvej 28, 3460 Birkerød, den 15.07.2020.
Bestyrelse:
Fratrådte:
Kim Stengaard Holmsted, (formand), den 22.06.2020, Hans Heugh Wandall, den 22.06.2020.
Tiltrådte:
Søren Erik Bjørn, den 22.06.2020, Hans Heugh Wandall, (formand), den 22.06.2020.
Vedtægter ændret: 01.06.2019
Ny adresse: Ole Maaløes Vej 3, 2200 København N
Ny kommune: København
Bestyrelse:
Fratrådte:
Kurt Flemming Holmsted, den 01.06.2019.
Tiltrådte:
Thomas Dal Stenfeldt Batchelor, den 01.06.2019, Johan Henrik Faber, den 01.06.2019.
Direktion:
Fratrådte:
Kurt Flemming Holmsted, den 01.06.2019.
Tiltrådte:
Johan Henrik Faber, den 01.06.2019.
Selskabet tegnes afdirektionen i forening med bestyrelsesformanden eller af den samlede bestyrelse..
Stiftelsesdato: 10.09.2018.
Virkningsdato: 10.09.2018.
Seneste vedtægtsdato: 10.09.2018.
Kapital:
kr. 50.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 50.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 39807556 Ebumab Holding ApS, Endrupvej 41, 3480 Fredensborg, den 10.09.2018.
Bestyrelse:
Kim Stengaard Holmsted (formand), den 10.09.2018, Kurt Flemming Holmsted, den 10.09.2018, Hans Heugh Wandall, den 10.09.2018.
Direktion:
Kurt Flemming Holmsted, den 10.09.2018.
Selskabet tegnes af én direktør sammen med bestyrelsesformanden eller af den samlede bestyrelse..
Revision:
CVR-NR. 11790577 KAPPELSKOV REVISION. GODKENDT REVISIONSAKTIESELSKAB, Milnersvej 7, 3400 Hillerød, den 10.09.2018.
Første regnskabsår:
10.09.2018 - 31.12.2019.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at drive virksomhed indenfor forskning, udvikling og markedsføring af farmaceutiske og medicinske præparater samt anden efter bestyrelsens skøn beslægtet virksomhed.
1 registered in CVR.
P-number 1023951386Ole Maaløes Vej 3, 2200 København N
